Vimarsana
Biggest News Aggregation in the World

Biotech Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biotech Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biotech Pharma Today - Breaking & Trending Today

Cuba and China in the dynamics of a multi-sector alliance - Vimarsana News

Cuba and China in the dynamics of a multi-sector alliance

Beijing (Prensa Latina) China and Cuba have reinvigorated their economic-commercial relations, strengthened mutual political trust with high-level meetings and signed several agreements during a fruitful year for their ties.

CID visits NMRA for human immunoglobulin IV probe - Vimarsana News

CID visits NMRA for human immunoglobulin IV probe

Latest news, analysis and opinions from the Daily FT, Sri Lanka's only national business newspaper. ..

Source: ft.lk
Saga over errant drug company: Health Ministry seeks AG's advice - Breaking News - Vimarsana News

Saga over errant drug company: Health Ministry seeks AG's advice - Breaking News

Dailymirror.lk – Sri Lanka 24 Hours Online Breaking News : News, Politics, Video, Finance, Business, Sports, Entertainment, Travel, sri lanka news,sri lanka latest news, latest breaking news, latest political news, covid-19 news,covid-19 news sri lanka, Sri Lanka Coronavirus updates, sl news, sl covid-19 news, SL breaking news, daily news, breaking news in sri lanka

Chinese scientists highlight the social impact of Cuban medicine - Vimarsana News

Chinese scientists highlight the social impact of Cuban medicine

Beijing, Aug 5 (Prensa Latina) Chinese scientists highlighted the social impact in China of Nimotuzumab, Cuba's humanized monoclonal antibody approved for the treatment of pancreatic cancer.

Cuban Nimotuzumab drug to get registered in China - Vimarsana News

Cuban Nimotuzumab drug to get registered in China

Beijing, Jun 20 (Prensa Latina) Cuba's humanized monoclonal antibody Nimotuzumab got registered in China to treat pancreatic cancer, since it benefits patients and commercialization possibilities in China and other foreign markets.